These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6329763)

  • 1. Secondary tumors after high-dose cyclophosphamide and total-body irradiation followed by bone marrow transplantation in a rat model for human acute myelocytic leukemia (BNML).
    Lopes Cardozo B; Martens AC; Zurcher C; Hagenbeek A
    Eur J Cancer Clin Oncol; 1984 May; 20(5):695-8. PubMed ID: 6329763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high-dose cyclophosphamide in combination with total-body irradiation in the treatment of acute myelocytic leukemia: studies in a relevant rat model.
    Hagenbeek A; Martens AC
    Cancer Res; 1983 Jan; 43(1):408-12. PubMed ID: 6336603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cyclophosphamide treatment of acute myelocytic leukemia. Studies in the BNML rat model.
    Hagenbeek A; Martens AC
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):763-9. PubMed ID: 6759141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.
    el-Beltagi HM; Martens AC; Dahab GM; Hagenbeek A
    Leukemia; 1993 Nov; 7(11):1795-800. PubMed ID: 8231248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG treatment of residual disease in acute leukemia: studies in a rat model for human acute myelocytic leukemia (BNML).
    Hagenbeek A; Martens AC
    Leuk Res; 1983; 7(4):547-55. PubMed ID: 6578394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late effects of cyclophosphamide and total body irradiation as a conditioning regimen for bone marrow transplantation in rats (a preliminary report).
    Zurcher C; Varekamp AE; Solleveld HA; Durham SK; De Vries AJ; Hagenbeek A
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jun; 51(6):1059-68. PubMed ID: 3298105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML.
    Messner HA; Curtis JE; Minden MM
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):187-9. PubMed ID: 3892701
    [No Abstract]   [Full Text] [Related]  

  • 9. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental studies on the elimination of minimal residual leukemia in vivo by alternate half body irradiation].
    Chu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):12-6. PubMed ID: 8324833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
    Martens AC; de Groot CJ; Hagenbeek A
    Eur J Cancer; 1991; 27(2):161-6. PubMed ID: 1827281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
    Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
    Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
    Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia.
    Martens AC; Hagenbeek A
    Eur J Cancer; 1999 Apr; 35(4):634-40. PubMed ID: 10492639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase involvement in a variant of the brown Norway rat acute myelocytic leukaemia (BNML) that acquired cyclophosphamide resistance in vivo.
    de Groot CJ; Martens AC; Hagenbeek A
    Eur J Cancer; 1994; 30A(14):2137-43. PubMed ID: 7857714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
    Martens AC; van Bekkum DW; Hagenbeek A
    Int J Cell Cloning; 1990 Jan; 8(1):27-38. PubMed ID: 2403582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.